PVLA vs APGE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
APGE Captures Institutional Edge (2โ1 Pillars ยท 5โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Apogee Therapeutics, Inc. Common Stock (APGE) driven by superior Growth & Margin, Momentum & Technical while PVLA counters with relative strength in Options & Structure. Fundamentally, PVLA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus APGE at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro) against APGE sits in UNCLASSIFIED (1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PVLA | APGE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.2B | $10.2B | Larger Scale | APGE |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -63.4% | -32.5% | Higher ROE | APGE |
| 52-Week Range Position Momentum | 68% ($72โ$180) | 100% ($35โ$135) | Stronger Trend | APGE |
| Beta / 30D Volatility Risk Regime | 1.66ฮฒ ยท 75% Vol | 0.71ฮฒ ยท 1% Vol | Lower Realized Risk | APGE |
| Unified Institutional Score Composite Signal | 48.2 / 100 (HOLD) | 54.9 / 100 (HOLD) | Higher Composite | APGE |